Minimum Order Quantity in Pharma Manufacturing Explained
Minimum Order Quantity (MOQ) in pharma manufacturing is the term used for the smallest batch size or unit count that a plant will accept to produce. In India, a typical MOQ ranges from 1,00,000 units for tablets and capsules to 5,000 units for oral liquids.
When going for a third-party pharma manufacturing partner, pharma companies should have a complete understanding of the minimum order quantity. An MOQ decides how many units, boxes, strips, bottles, or batches of medicines will be produced in a plant for a specific client. Through this comprehensive guide, let’s understand minimum order quantity in detail, along with strategies to prescribe MOQ, benefits, factors affecting it, common mistakes to avoid, and more.
What is Minimum Order Quantity in Pharma?
Minimum Order Quantity, also known as MOQ, refers to the minimum quantity that a pharma company asks the third-party manufacturer to produce. Some common products include capsules, bottles, tubes, sachets, or batches. For example, if a third-party pharma manufacturing company says that the MOQ is 500 boxes, then it means you need to order at least 500 boxes to begin production. This approach helps manufactuers in managing the overall production cost, buying of raw materials, packaging printing, and other essential aspects of the Pharmaceutical Manufacturing Process.
Why Do Manufacturers Set MOQs?
A Pharma Third Party Manufacturing Company in India sets a minimum order quantity for the following reasons:
- Supply Chain Stability: When a manufacturer has a predictable volume of the medicine to be produced, it helps in better raw material planning and supply chain stability.
- Profitability: Having a Pharma Manufacturing MOQ approach helps pharma manufacturing companies maintain profitability and cover essential costs like setup expenses, labor, and material costs.
- Efficiency in production: Manufacturers can easily maintain their production efficiency as the minimum order aligns with equipment throughout the batch sizing.
- Economies of Scale: One of the key reasons third-party manufacturers set an MOQ is that it reduces the overall unit cost and waste of materials.
For Quotes & Pricing — We Reply Within 24 Hours
General MOQ for Pharma Third-Party Manufacturing
The Pharma Manufacturing MOQ depends on the type of product, manufacturer, packaging, and raw material availability. Here is a table showcasing some of the common MOQ ranges for diverse pharmaceutical products:
| Product Type | Common MOQ | Key Information |
|---|---|---|
| Tablets & Capsules | 50,000–1,00,000 units | Trial batches may start from 10,000–25,000 units. Smaller manufacturers often offer more flexible MOQs. |
| Liquid Syrups | 1,000–5,000 bottles | MOQ depends on bottle size, packaging materials, and label availability. |
| Dry Syrups | 3,000–10,000 bottles | Production process and packaging requirements usually increase the minimum order quantity for pharmaceutical products. |
| Ointments, Creams & Gels | 1,000–5,000 tubes | Custom printed tubes generally require higher MOQs than standard packaging. |
| Injections | 2,000–10,000 vials/ampoules | MOQ depends on sterile manufacturing, product type, and packaging requirements. |
| Sachets | 5,000–30,000 sachets | Final MOQ varies according to sachet size, filling quantity, and packaging rolls. |
| Softgel Capsules | 30,000–1,00,000 softgels | MOQ is generally higher because of specialized manufacturing and filling processes. |
| Protein Powder & Granules | 500–2,000 jars | Packaging type such as jars, tins, or pouches affects the final MOQ. |
| Ayurvedic Products | 500–1,00,000 units | MOQ differs by product. Many manufacturers offer flexible quantities for startups. |
| Nutraceutical Products | 500–1,00,000 units | MOQ depends on product type, ingredient cost, packaging, and regulatory category. |
Factors Affecting Minimum Order Quantity
The minimum order quantity in pharma is often affected by several factors. Key elements like product type, raw material cost, packaging, and batch size can impact the overall value. Let’s take a closer look:
- Availability of Raw Materials: Usually, the MOQ is lower if the raw material is easily available. However, for extraordinary or costly materials, pharma businesses can expect higher MOQ from manufacturers.
- Product Category: Different kinds of products have different MOQ. For example, MOQ for tablets or capsules might be between 50,000 and 1,00,000 units, but for syrups, it could be 3000-10,000 bottles.
- Packaging Type: The type of packaging has a huge impact on the overall MOQ value. Blister packing, alu-alu packing, bottle packing, tube packing, and sachet packing have different production requirements. Therefore, medicine manufacturing companies in India consider this aspect to identify their MOQ.
- Batch Size: Manufacturers have machines that can produce a specific quantity of products. Therefore, the value of Third Party Pharma Manufacturing MOQ is often dependent on the machine capacity and batch feasibility.
Why Pharma Businesses Prefer Low MOQ?
Many new pharma businesses look for a third party manufacturing firm in India that offers low minimum order quantity for pharmaceutical products. This is because it is less risky and allows for easier market entry. Some of the key advantages of low MOQs are as follows:
- Lower Initial Investment: Pharma businesses search for third party pharma manufacturing firms that offer lower MOQ because it helps them start their operations with less capital. Moreover, it makes it easy for them to launch products in the market without any heavy financial burden.
- Reduced Business Risk: Ordering small batches of medicines helps pharma companies avoid excess inventory and minimize losses if a product does not perform well in the market.
- Quick Market Entry: Low Minimum Order Quantity in Pharma Manufacturing is a gateway for quick entry into the healthcare market. Businesses can launch products quickly, test consumer demand, and start generating sales without having to wait for large production investments.
- Good Inventory Management: Smaller batch sizes of capsules, tablets, syrups, softgels, and more make it easy for pharma companies to manage stock. In addition, it also leads to a reduction in expiry risks and maintenance of healthy inventory levels.
- Flexibility to Expand: If a pharma business performs well with small batch sizes and gets good results for testing products first, it can expand production later on the basis of consumer demand.
Conclusion
Opening a pharma business is one of the most beneficial ideas as the Indian healthcare industry is experiencing significant development. However, starting small is always a good option as gradual growth lasts longer. Choose a Pharma Contract Manufacturing company that offers low MOQ, which further helps you reduce financial risk, helps you test your product first, and gives your business the flexibility to expand slowly.
If you are searching for such a company, look no further than Medella Softgel. We are one of the top third-party pharma manufacturing companies in India that offer low MOQ options for your business. However, we do not compromise on quality and produce everything with adherence to WHO-GMP guidelines. Moreover, we have modern manufacturing units, conduct strict quality control checks, and offer timely delivery to our clients. You can surely partner with us, describe your order, and expand your product portfolio with us.
Also Read: Pharmacovigilance Basics for Pharma Companies in India In 2026
Frequently Asked Questions
Minimum Order Quantity is the minimum number of units a manufacturer requires for producing a pharmaceutical product.
Manufacturers set minimum order values because it helps them cover the costs of production, packaging, raw materials, and other crucial expenses.
Factors that affect MOQ include product type, raw materials, packaging, production process, and manufacturer’s policies.
The typical MOQ ranges from 500 units to 1,00,000 units, depending on the product category.
Yes. Different pharmaceutical products have different production and packaging requirements, which further result in varied MOQs.
Small pharma companies often choose manufacturers that offer low MOQ. This is because it helps them start their business with fewer products and quick entry into the market.
Yes. Many third-party manufacturers in India provide flexible low MOQ options to support startups and small businesses.
The minimum investment to start a third-party pharma manufacturing depends on the product and quantity, but low MOQ options reduce the initial investment.
Lower MOQs usually have a higher cost per unit, while larger orders generally reduce the overall unit price.
MOQ is the minimum quantity you can order, while batch size is the total quantity produced in one manufacturing cycle.
Third-party pharma manufacturing companies consider several factors, such as production costs, raw material requirements, packaging availability, equipment capacity, and product demand, to decide MOQ.
Yes. Many manufacturers offer low MOQ options, which makes it easier for new businesses to enter the market.
Pharma companies can work with manufacturers that offer flexible production quantities and standard packaging options.
To partner with the right third party pharma manufacturing company in India, check their quality certifications, modern manufacturing facilities, transparent pricing, low MOQ options, and reliable customer support.
